ArticleOncotarget2016

Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

Valentina Salizzato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.